Why Relief Therapeutics (RLFTF) will trade higher
On Monday, May 31st, NeuroRX a company that develops drugs for COVID-19 respiratory failure and suicidal bipolar depression announced that it has completed it’s merger with Black Rock Acquisition Corp (BRPA). The deal reflects a valuation of $1.5 billion and…